Contrave FDA Approval History
FDA Approved: Yes (First approved September 10, 2014)
Brand name: Contrave
Generic name: bupropion and naltrexone
Dosage form: Tablets
Company: Orexigen Therapeutics, Inc.
Treatment for: Anti-obesity Medications for Weight Loss (Obesity/Overweight)
Contrave (bupropion/naltrexone) is an aminoketone antidepressant and opioid antagonist combination indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management.
Development timeline for Contrave
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.